SCHEMBL3880004

SCHEMBL3880004

O=C(O)c1cnccc1CO

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 16/20 0.50
KDM6B O15054 7/20 0.50
KDM4D Q6B0I6 4/20 0.50
KDM4E B2RXH2 2/20 0.50
KDM4A O75164 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
ALDH1A1 P00352 2/20 0.50
MEN1 O00255 1/20 0.50
MAPT P10636 1/20 0.50
THRB P10828 1/20 0.50
KMT2A Q03164 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
USP2 O75604 1/20 0.41
SIRT3 Q9NTG7 1/20 0.40
NAPRT Q6XQN6 1/20 0.40
APP P05067 1/20 0.39
GAA P10253 1/20 0.39
HCAR3 P49019 1/20 0.39
HCAR2 Q8TDS4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9858541 0.85 KDM4C (0.47) KDM4CKDM6BKDM4DKDM4EKDM4A
SCHEMBL123203 0.84 KDM4C (0.51) KDM4CKDM6BKDM4DKDM4EKDM4A
SCHEMBL31132830 0.84 KDM4C (0.55) KDM4CKDM6BKDM4DKDM4EKDM4A
SCHEMBL31132789 0.84 KDM4C (0.55) KDM4CKDM6BKDM4DKDM4EKDM4A
SCHEMBL30465694 0.84 KDM4C (0.51) KDM4CKDM6BKDM4DKDM4EKDM4A
SCHEMBL3931892 0.82 KDM4C (0.48) KDM4CKDM6BKDM4DKDM4EKDM4A
SCHEMBL6207070 0.82 KDM4C (0.48) KDM4CKDM6BKDM4DKDM4EKDM4A
SCHEMBL7509912 0.82 KDM4C (0.48) KDM4CKDM6BKDM4DKDM4EKDM4A
SCHEMBL2479238 0.82 KDM4C (0.53) KDM4CKDM6BKDM4DKDM4EKDM4A
SCHEMBL7263236 0.82 KDM4C (0.48) KDM4CKDM6BKDM4DKDM4EKDM4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4301744-A1 NICOTINAMIDE RIPK1 INHIBITORS AbbVie Inc. (US) 2024-01-10 EP disclosed
WO-2023018643-A1 NICOTINAMIDE RIPK1 INHIBITORS ABBVIE INC. (US) 2023-02-16 WO disclosed
EP-2111400-A1 PYRIDINE COMPOUNDS AND THEIR USE AS P2Y12 ANTAGONISTS. AstraZeneca AB (SE) 2009-10-28 EP disclosed
WO-2008085117-A1 PYRIDINE COMPOUNDS AND THEIR USE AS P2Y12 ANTAGONISTS. ASTRAZENECA AB (SE) 2008-07-17 WO disclosed
US-20060189774-A1 Modifiable polyunsaturated polymers and processes for their preparation AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH 2006-08-24 US disclosed